These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1958475)

  • 1. Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.
    Shepherd PC; Fooks J; Gray R; Allan NC
    Br J Haematol; 1991 Oct; 79(2):185-92. PubMed ID: 1958475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia.
    Key NS; Kelly PM; Emerson PM; Chapman RW; Allan NC; McGee JO
    Lancet; 1987 Nov; 2(8567):1050-2. PubMed ID: 2889964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal hypertension in a patient with chronic myeloid leukaemia.
    Foadi MD; Shaw S; Paradinas FJ
    Postgrad Med J; 1977 May; 53(619):267-9. PubMed ID: 267281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic portal hypertension associated with cytotoxic drugs.
    Shepherd P; Harrison DJ
    J Clin Pathol; 1990 Mar; 43(3):206-10. PubMed ID: 2332518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients.
    van Asseldonk DP; Simsek M; de Boer NKH; Jharap B; Bloemena E; den Hartog G; Westerveld DB; Becx MC; Russel MG; Lissenberg-Witte BI; van Nieuwkerk CM; Mulder CJJ; Verheij J; van Bodegraven AA
    Scand J Gastroenterol; 2019 Jun; 54(6):753-760. PubMed ID: 31203688
    [No Abstract]   [Full Text] [Related]  

  • 6. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
    Ravikumara M; Hill FG; Wilson DC; Gillett PM; Thomas A; Brown R; Darbyshire PJ; McKiernan PJ
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):535-8. PubMed ID: 16707977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.
    Broxson EH; Dole M; Wong R; Laya BF; Stork L
    Pediatr Blood Cancer; 2005 Mar; 44(3):226-31. PubMed ID: 15503293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marrow aplasia developing 3 years after treatment with busulphan for chronic myeloid leukaemia.
    Bowcock SJ; Galton DA; Goldman JM
    Eur J Haematol; 1989 May; 42(5):496-7. PubMed ID: 2567249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
    Shepherd PC; Richards S; Allan NC
    Br J Haematol; 1994 Jan; 86(1):92-6. PubMed ID: 8011552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy in a patient receiving busulphan for chronic myeloid leukaemia.
    Norhaya MR; Cheong SK; Hamidah NH; Ainoon O
    Singapore Med J; 1994 Feb; 35(1):102-3. PubMed ID: 8009265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of children with 6-thioguanine-related chronic hepatoxicity following treatment for acute lymphoblastic leukaemia.
    Rawat D; Gillett PM; Devadason D; Wilson DC; McKiernan PJ
    J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):478-9. PubMed ID: 21701407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
    Ferlitsch A; Teml A; Reinisch W; Ulbrich G; Wrba F; Homoncik M; Gangl A; Peck-Radosavljevic M; Vogelsang H
    Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foetal liver infusion in a chronic myeloid leukemia patient with busulphan toxicity.
    Sharma S; Kochupillai V; Pati HP
    Med Oncol; 1998 Apr; 15(1):70-1. PubMed ID: 9643535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.
    Gioia S; Nardelli S; Pasquale C; Pentassuglio I; Nicoletti V; Aprile F; Merli M; Riggio O
    Dig Liver Dis; 2018 Aug; 50(8):839-844. PubMed ID: 29429910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cancer after busulphan treatment for chronic myeloid leukemia. A case report.
    Iurlo A; Foa P; Sala M; Maiolo AT
    Tumori; 1993 Aug; 79(4):278-9. PubMed ID: 8249184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
    Olsson-Strömberg U; Simonsson B; Ahlgren T; Björkholm M; Carlsson K; Gahrton G; Hast R; Löfvenberg E; Linder O; Ljungman P; Malm C; Paul C; Rödjer S; Turesson I; Udén AM; Wahlin A; Killander A; Wadman B; Westin J; Vikrot O; Zettervall O; Oberg G;
    Hematol J; 2004; 5(6):462-6. PubMed ID: 15570285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.
    De Bruyne R; Portmann B; Samyn M; Bansal S; Knisely A; Mieli-Vergani G; Dhawan A
    J Hepatol; 2006 Feb; 44(2):407-10. PubMed ID: 16226335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation between the duration of the chronic phase of chronic myeloid leukemia and total dose of busulfan in the first year of the treatment].
    Hellmann A; Koberda J; Baran W
    Acta Haematol Pol; 1990; 21(1):60-5. PubMed ID: 2260409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichosporon beigelii pneumonitis following busulphan-induced leucopenia.
    Yamauchi K; Sato T
    Eur Respir J; 1992 May; 5(5):594-7. PubMed ID: 1612161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioguanine as primary treatment for chronic granulocytic leukaemia.
    Spiers AS; Galton DA; Kaur J; Goldman JM
    Lancet; 1975 Apr; 1(7911):829-32. PubMed ID: 48057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.